§ 54.1-2523.1. Criteria for indicators of misuse; Director's authority to disclose information; intervention...
The Director shall develop, in consultation with an advisory panel, criteria for indicators of misuse and a method for analysis of data collected by the Prescription Monitoring Program using the criteria for indicators of misuse. Upon the development of such criteria and data analysis, the Director may, in addition to the discretionary disclosure of information pursuant to § 54.1-2523, disclose information using the criteria that indicates potential misuse by recipients of covered substances to their specific prescribers for the purpose of intervention to prevent such misuse.
(2005, cc. 637, 678.)
Sections: Previous 54.1-2519 54.1-2520 54.1-2521 54.1-2522 54.1-2523 54.1-2523.1 54.1-2524 54.1-2525 NextLast modified: April 16, 2009